Phosphorylation of ERK-Dependent NF-κB Triggers NLRP3 Inflammasome Mediated by Vimentin in EV71-Infected Glioblastoma Cells.
Child
Child, Preschool
Enterovirus
/ metabolism
Glioblastoma
/ genetics
Humans
Inflammasomes
/ metabolism
Mitogen-Activated Protein Kinase 1
/ metabolism
Mitogen-Activated Protein Kinase 3
/ metabolism
NF-kappa B
/ metabolism
NLR Family, Pyrin Domain-Containing 3 Protein
/ genetics
Phosphorylation
Vimentin
/ genetics
NF-κB
NLRP3
enterovirus 71
glioblastoma cells
phosphorylation of ERK1/2
vimentin
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
29 Jun 2022
29 Jun 2022
Historique:
received:
25
05
2022
revised:
17
06
2022
accepted:
27
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Enterovirus 71 (EV71) is a dominant pathogenic agent that may cause severe central nervous system (CNS) diseases among infants and young children in the Asia-pacific. The inflammasome is closely implicated in EV71-induced CNS injuries through a series of signaling pathways. However, the activation pathway of NLRP3 inflammasome involved in EV71-mediated CNS injuries remains poorly defined. In the studies, EV71 infection, ERK1/2 phosphorylation, and activation of NLRP3 are abolished in glioblastoma cells with low vimentin expression by CRISPR/Cas9-mediated knockdown. PD098059, an inhibitor of p-ERK, remarkably blocks the vimentin-mediated ERK1/2 phosphorylation in EV71-infected cells. Nuclear translocation of NF-κB p65 is dependent on p-ERK in a time-dependent manner. Moreover, NLRP3 activation and caspase-1 production are limited in EV71-infected cells upon the caffeic acid phenethyl ester (CAPE) administration, an inhibitor of NF-κB, which contributes to the inflammasome regulation. In conclusion, these results suggest that EV71-mediated NLRP3 inflammasome could be activated via the VIM-ERK-NF-κB pathway, and the treatment of the dephosphorylation of ERK and NF-κB inhibitors is beneficial to host defense in EV71-infected CNS.
Identifiants
pubmed: 35807435
pii: molecules27134190
doi: 10.3390/molecules27134190
pmc: PMC9268588
pii:
doi:
Substances chimiques
Inflammasomes
0
NF-kappa B
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
NLRP3 protein, human
0
VIM protein, human
0
Vimentin
0
Mitogen-Activated Protein Kinase 1
EC 2.7.11.24
Mitogen-Activated Protein Kinase 3
EC 2.7.11.24
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : The Basic Research Project of Key Laboratory of Guangzhou,China
ID : 202102100001
Organisme : Grant from School of Public Health of SoutheZrn Medical University, China
ID : GW202116
Références
Microbes Infect. 2010 Jul;12(7):505-10
pubmed: 20348010
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
Cell Rep. 2015 Jul 7;12(1):42-48
pubmed: 26119741
PLoS Pathog. 2017 Jan 6;13(1):e1006123
pubmed: 28060938
PLoS One. 2012;7(3):e32405
pubmed: 22479324
Nat Rev Urol. 2017 May;14(5):284-295
pubmed: 28266511
Neuron. 2005 Mar 3;45(5):715-26
pubmed: 15748847
PLoS One. 2013 Sep 20;8(9):e73900
pubmed: 24073199
Rev Med Virol. 2015 Mar;25(2):115-28
pubmed: 25704797
Pharmacol Rep. 2017 Oct;69(5):1030-1035
pubmed: 28958612
Int Immunopharmacol. 2018 Jul;60:111-120
pubmed: 29730555
Cell Signal. 2010 Feb;22(2):234-46
pubmed: 19800403
Clin Exp Vaccine Res. 2017 Jan;6(1):4-14
pubmed: 28168168
Neurosci Lett. 2017 May 10;649:100-106
pubmed: 28392360
Front Immunol. 2020 Oct 05;11:551449
pubmed: 33123130
Neurocrit Care. 2017 Aug;27(1):44-50
pubmed: 28181102
Virol Sin. 2012 Aug;27(4):254-8
pubmed: 22899434
Front Immunol. 2018 May 04;9:983
pubmed: 29780394
Annu Rev Cell Dev Biol. 2012;28:137-61
pubmed: 22974247
Brain. 2017 Sep 1;140(9):2273-2285
pubmed: 29050380
Lancet Infect Dis. 2010 Nov;10(11):778-90
pubmed: 20961813
Int Rev Immunol. 2018 Jan 2;37(1):57-68
pubmed: 28961037
Front Immunol. 2016 Dec 05;7:540
pubmed: 27994587
Curr Treat Options Neurol. 2017 May;19(5):19
pubmed: 28417344
N Engl J Med. 2014 Feb 27;370(9):792-4
pubmed: 24571750
Cell Signal. 2006 Jul;18(7):994-1005
pubmed: 16242916
J Hematol Oncol. 2016 Nov 14;9(1):122
pubmed: 27842563
Sci Rep. 2016 Dec 14;6:39303
pubmed: 27966632
Nat Commun. 2015 Mar 12;6:6574
pubmed: 25762200
J Neurosci. 2010 Nov 24;30(47):15811-20
pubmed: 21106820
J Microbiol Immunol Infect. 2000 Dec;33(4):205-16
pubmed: 11269363
Lancet Infect Dis. 2014 Apr;14(4):308-318
pubmed: 24485991
Virol J. 2017 Jan 11;14(1):2
pubmed: 28081706
J Virol. 2014 May;88(10):5816-33
pubmed: 24623428
J Virol. 2017 Jun 9;91(13):
pubmed: 28424281
FEMS Microbiol Rev. 2002 Mar;26(1):91-107
pubmed: 12007645
Viruses. 2015 Mar 20;7(3):1344-56
pubmed: 25803100
Viruses. 2015 Dec 14;7(12):6613-30
pubmed: 26694447